| Drug Name |
Clemastine fumarate |
| Drug ID |
BADD_D00481 |
| Description |
An ethanolamine-derivative, first generation histamine H1 antagonist used in hay fever, rhinitis, allergic skin conditions, and pruritus. It causes drowsiness. |
| Indications and Usage |
For the relief of symptoms associated with allergic rhinitis such as sneezing, rhinorrhea, pruritus and acrimation. Also for the management of mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Used as self-medication for temporary relief of symptoms associated with the common cold. |
| Marketing Status |
approved; investigational |
| ATC Code |
D04AA14; R06AA04 |
| DrugBank ID |
DB00283
|
| KEGG ID |
D00666
|
| MeSH ID |
D002974
|
| PubChem ID |
5281069
|
| TTD Drug ID |
D0C5XC
|
| NDC Product Code |
62135-713; 73377-061; 73308-358; 0093-0308; 55152-001 |
| UNII |
19259EGQ3D
|
| Synonyms |
Clemastine | Mecloprodin | 2-(2-(1-(4-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine | Meclastine | Tavist | Tavegyl | Clemastine Fumarate | HS-592 | HS 592 | HS592 |
